Two of President Donald Trump’s choices to lead major health agencies will face Senate confirmation this week, while two ...

With a U.S. green light for its encapsulated cell therapy technology in the bag, privately held biotech Neurotech ...

Biodexa Announces Successful Outcome of a Type C Meeting with FDA Regarding the Phase 3 Program for eRapa in FAP Clears the ...

Q4 2024 Earnings Call Transcript March 6, 2025 Phathom Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0 ...

Researchers are working on a device that uses artificial intelligence to guide the delivery of pain management drugs for ...

Mineralys Therapeutics' lorundrostat shows promising Phase 3 results in treating resistant hypertension, with 9.1 mmHg blood ...

At the recent CBER agency workshop on cell therapies and tissue-based products, a few surprising ideas discussed could have ...

The Society for the Conservation of Nature of Liberia (SCNL) at its 39th Anniversary retires its Broad Chair Mr. Alexander L. Peal and Prof. John T. Woods as member of broad. The two happened to be ...

A simple treatment algorithm to aid in the selection of appropriate DMTs reduces racial disparities in patients with ...

One of the most highly anticipated FDA decisions this month is for Alnylam Pharmaceuticals, which is seeking to expand the ...

A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...